Hydroxproline Catabolism and Hyperoxaluria
羟脯氨酸分解代谢和高草酸尿症
基本信息
- 批准号:8075595
- 负责人:
- 金额:$ 27.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-06-01 至 2013-05-31
- 项目状态:已结题
- 来源:
- 关键词:Alanine-glyoxylate aminotransferaseAnimalsBenchmarkingCalcium OxalateCatabolismCollagenCoupledDataDefectDegradation PathwayDepositionDetectionDietEnzymesExcretory functionExhibitsFoundationsFutureGelatinGeneticGlycineGlycolatesGlyoxylatesHumanHydroxyprolineHyperoxaluriaIntravenous infusion proceduresKidneyKidney CalculiKidney FailureKnock-in MouseKnock-outKnockout MiceLabelLeadMetabolicMetabolismModelingMonitorMusOxalatesPathway interactionsPatientsPerfusionPrimary HyperoxaluriaProductionProteinsResearchRoleSourceTechniquesTestingTherapeuticTracerglyoxylateglyoxylate reductasehuman subjectinnovationmouse modelpublic health relevanceresearch studytherapeutic targettreatment strategyurinary
项目摘要
DESCRIPTION (provided by applicant): Primary hyperoxaluria types I and 2 (PH1 and PH2) are characterized by an inability to efficiently metabolize glyoxylate as a consequence of functional defects in alanine-glyoxylate aminotransferase and glyoxylate reductase, respectively. Excessive oxalate synthesis results and may ultimately cause renal failure. To date, there are no therapies that can specifically reduce oxalate synthesis. Hydroxyproline metabolism is the only recognized source of glyoxylate that has been identified to date. We hypothesize that the breakdown of dietary and endogenous hydroxyproline contributes to the bulk of the oxalate synthesized in PH1 and PH2 patients. Confirmation of this hypothesis would suggest that the inhibition of hydroxyproline degradation may be a significant therapeutic opportunity for diminishing endogenous oxalate production in PH patients. As a first step toward testing this hypothesis, we have synthesized homogeneously labeled 13C-hydroxyproline and verified that it can be used to follow the degradation of hydroxyproline to oxalate, glycolate, lactate, and glycine using chromatographic techniques coupled to mass detection. The specific aims of the proposed research are: (1) to quantitate the contribution of hydroxyproline metabolism to endogenous oxalate synthesis in normal human subjects and patients with PH using homogeneously-labeled Hyp, 13C5-hydroxyproline, as a metabolic tracer; (2) to quantitate the contribution of hydroxyproline metabolism to endogenous oxalate synthesis in mouse KO models of PH (Agxt and Grhpr KO) using 13C5-hydroxyproline. Through the quantitation and tracking of the isotopic label within metabolites, we will be able to demonstrate whether or not hydroxyproline degradation contributes to endogenous glycolate, and oxalate synthesis. Moreover, the mouse data will benchmark the contribution of hydroxyproline to urinary glycolate and oxalate in each genetic setting. This latter data will be invaluable for the future testing of therapeutics targeting the unique enzymes of the hydroxyproline degradation pathway.
PUBLIC HEALTH RELEVANCE: The synthesis of oxalate, a key component of kidney stones, is influenced by glyoxylate levels. Glyoxylate is produced from hydroxyproline during the normal degradation of collagen within the body and that consumed in the diet. The purpose of this study is to determine whether or not hydroxyproline degradation contributes adversely to the elevated levels of glyoxylate and oxalate production observed in primary hyperoxaluria patients.
描述(申请人提供):原发性高草酸尿症I型和2型(PH1和PH2)的特征是由于丙氨酸-乙氧基酸氨基转移酶和乙氧基酸还原酶功能缺陷而无法有效代谢乙醛。草酸合成过多会导致最终导致肾功能衰竭。到目前为止,还没有专门减少草酸合成的疗法。羟脯氨酸代谢是迄今为止唯一已被确认的乙氧基酸来源。我们假设,在PH1和PH2患者中,膳食和内源性羟脯氨酸的分解是草酸合成的主要原因。这一假说的证实将表明,抑制羟脯氨酸降解可能是减少PH患者内源性草酸产生的重要治疗机会。作为验证这一假说的第一步,我们已经合成了均相标记的13C-羟基脯氨酸,并验证了它可以用来跟踪羟基脯氨酸降解为草酸、乙醇酸、乳酸和甘氨酸的过程,使用与质量检测相结合的色谱技术。这项研究的具体目的是:(1)使用均相标记的Hyp,13C5-羟脯氨酸作为代谢示踪剂,定量研究正常人和PH患者羟脯氨酸代谢对内源性草酸合成的贡献;(2)使用13C5-羟脯氨酸定量研究PHKO模型(Agxt和Grhpr KO)中羟脯氨酸代谢对内源性草酸合成的贡献。通过对代谢物中同位素标记的定量和跟踪,我们将能够证明羟脯氨酸降解是否有助于内源性乙醇酸和草酸的合成。此外,小鼠的数据将基准羟脯氨酸对尿乙醇酸和草酸在每个遗传环境中的贡献。后一项数据将对未来针对羟脯氨酸降解途径的独特酶的疗法测试具有非常重要的价值。
公共卫生相关性:草酸的合成是肾结石的关键成分,它的合成受到乙醛水平的影响。乙醛是在体内胶原蛋白正常降解的过程中由羟基脯氨酸产生的,并在饮食中消耗。这项研究的目的是确定羟脯氨酸降解是否对观察到的原发性高草酸尿症患者乙醛酸和草酸产生水平的升高有不利影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROSS P HOLMES其他文献
ROSS P HOLMES的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROSS P HOLMES', 18)}}的其他基金
Influence of Obesity on Endogenous Oxalate Synthesis
肥胖对内源性草酸合成的影响
- 批准号:
10167931 - 财政年份:2018
- 资助金额:
$ 27.03万 - 项目类别:
Influence of Obesity on Endogenous Oxalate Synthesis
肥胖对内源性草酸合成的影响
- 批准号:
10265575 - 财政年份:2018
- 资助金额:
$ 27.03万 - 项目类别:
Mitochondrial Metabolism in Primary Hyperoxaluria
原发性高草酸尿症的线粒体代谢
- 批准号:
8926129 - 财政年份:2014
- 资助金额:
$ 27.03万 - 项目类别:
INFLUENCE OF GLYCINE BLOOD CONCENTRATION ON ITS METABOLISM TO OXALATE
甘氨酸血液浓度对其草酸盐代谢的影响
- 批准号:
8167055 - 财政年份:2010
- 资助金额:
$ 27.03万 - 项目类别:
Ninth International Primary Hyperoxaluria Workshop
第九届国际原发性高草酸尿症研讨会
- 批准号:
8007053 - 财政年份:2010
- 资助金额:
$ 27.03万 - 项目类别:
相似海外基金
The earliest exploration of land by animals: from trace fossils to numerical analyses
动物对陆地的最早探索:从痕迹化石到数值分析
- 批准号:
EP/Z000920/1 - 财政年份:2025
- 资助金额:
$ 27.03万 - 项目类别:
Fellowship
Animals and geopolitics in South Asian borderlands
南亚边境地区的动物和地缘政治
- 批准号:
FT230100276 - 财政年份:2024
- 资助金额:
$ 27.03万 - 项目类别:
ARC Future Fellowships
The function of the RNA methylome in animals
RNA甲基化组在动物中的功能
- 批准号:
MR/X024261/1 - 财政年份:2024
- 资助金额:
$ 27.03万 - 项目类别:
Fellowship
Ecological and phylogenomic insights into infectious diseases in animals
对动物传染病的生态学和系统发育学见解
- 批准号:
DE240100388 - 财政年份:2024
- 资助金额:
$ 27.03万 - 项目类别:
Discovery Early Career Researcher Award
Zootropolis: Multi-species archaeological, ecological and historical approaches to animals in Medieval urban Scotland
Zootropolis:苏格兰中世纪城市动物的多物种考古、生态和历史方法
- 批准号:
2889694 - 财政年份:2023
- 资助金额:
$ 27.03万 - 项目类别:
Studentship
Using novel modelling approaches to investigate the evolution of symmetry in early animals.
使用新颖的建模方法来研究早期动物的对称性进化。
- 批准号:
2842926 - 财政年份:2023
- 资助金额:
$ 27.03万 - 项目类别:
Studentship
Study of human late fetal lung tissue and 3D in vitro organoids to replace and reduce animals in lung developmental research
研究人类晚期胎儿肺组织和 3D 体外类器官在肺发育研究中替代和减少动物
- 批准号:
NC/X001644/1 - 财政年份:2023
- 资助金额:
$ 27.03万 - 项目类别:
Training Grant
RUI: Unilateral Lasing in Underwater Animals
RUI:水下动物的单侧激光攻击
- 批准号:
2337595 - 财政年份:2023
- 资助金额:
$ 27.03万 - 项目类别:
Continuing Grant
RUI:OSIB:The effects of high disease risk on uninfected animals
RUI:OSIB:高疾病风险对未感染动物的影响
- 批准号:
2232190 - 财政年份:2023
- 资助金额:
$ 27.03万 - 项目类别:
Continuing Grant
A method for identifying taxonomy of plants and animals in metagenomic samples
一种识别宏基因组样本中植物和动物分类的方法
- 批准号:
23K17514 - 财政年份:2023
- 资助金额:
$ 27.03万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)